EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept

Annika Sundlof, Michiko Taniguchi, Rohit Gupta iD, Mehri Mollaee, Francis Cordova, Kartik Shenoy iD, Steven Geier, Abdelhamid Liacini iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219424 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Annika Sundlof und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Autoantibodies, Graft Rejection, Abatacept. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of HLA donor-specific antibodies (DSAs), both before and after transplantation, is a well-established risk factor for antibody-mediated rejection (AMR) and poor graft survival. However, emerging evidence suggests that non-HLA antibodies may also provoke immune responses, contributing to rejection. Among these, antibodies targeting the angiotensin II type-1 receptor (AT1R) have been linked to adverse clinical outcomes in kidney and orthotopic heart transplant recipients. This case presents an investigation of non-HLA antibodies in a lung transplant recipient diagnosed with AMR in the absence of HLA DSAs, as well as the use of belatacept as part of a combination immunosuppressive regimen to treat AMR in a lung transplant recipient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationAutoantibodiesGraft RejectionAbataceptSteroidsHumansImmunosuppressive AgentsHLA AntigensAllograftsReceptor, Angiotensin, Type 1MaleFemaleMiddle Aged

Stichwörter der Autor:innen

AT1Rantibody-mediated rejection (AMR)autoantibodieslung transplantationrejection

Substanzen

AutoantibodiesAbataceptImmunosuppressive AgentsHLA AntigensSteroidsReceptor, Angiotensin, Type 1

Autor:innen und Institutionen

  • Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA.
  • Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
  • Immunogenetics Laboratory, Temple University Hospital, Philadelphia, PA 19140, USA.
  • Department of Thoracic Medicine and Surgery, Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
  • Histocompatibility Laboratory Services, American National Red Cross, 180 Rustcraft Road, Dedham, MA 02026, USA.

ORCID-Profile: Rohit Gupta, Kartik Shenoy, Abdelhamid Liacini

Zitieren

APA

Sundlof, A., Taniguchi, M., Gupta, R., Mollaee, M., Cordova, F., Shenoy, K., Geier, S., & Liacini, A. (2026). Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219424

Vancouver

Sundlof A, Taniguchi M, Gupta R, Mollaee M, Cordova F, Shenoy K, et al. Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219424

BibTeX
@article{Sundlof2026,
  author = {Sundlof, Annika and Taniguchi, Michiko and Gupta, Rohit and Mollaee, Mehri and Cordova, Francis and Shenoy, Kartik and Geier, Steven and Liacini, Abdelhamid},
  title = {Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219424}
}
Kostenlos starten →